Make an Appointment

Andrew Dale Campbell MD

Assistant Professor, Pediatrics
Specialties: 
Pediatric Hematology/Oncology, Pediatrics
Clinical Interests:

Dr. Campbell has an interest in clinical research in sickle cell disease including silent infarcts and neurocognitive functioning, the use of hydroxyurea, acute chest syndrome/pulmonary hypertesion, pain management

Video profile

Locations

U of M Pediatric Hematology Oncology

Cancer Center Floor B1 Reception B
1500 E Medical Center Dr SPC 5910
Ann Arbor
MI
48109
Phone:
734-936-9814
Fax:
734-936-5953

U of M Pediatric Hematology/Oncology

Medical Professional Building, D4202
1500 E Medical Center Dr SPC 5718
Ann Arbor
MI
48109
Phone:
734-764-7126
Fax:
734-615-0464

Credentials

Medical School or Training

  • Case Western Reserve University School of Medicine, 1996

Residency

  • Massachusetts General Hospital, Pediatrics, MA, 1999

Fellowship

  • Pediatric Hematology/Oncology, Children's Memorial Hospital (Lurie Children's Hospital of Chicago), 2002

Professional Organizations

  • National Medical Association

  • Children's Oncology Group

  • American Academy of Pediatrics

  • American Society of Hematology

  • Ernest E. Just Society

  • National Medical Association

  • Medical Student Section, American Medical Association

  • Morehouse College Alumni Association

  • Phi Beta Kappa Honor Society

Board Certification

  • Pediatric Hematology-Oncology

Research

  1. Pulmonary Hypertension in Sickle Cell Disease
  2. Phenotype/Genotype Studies within Twin and Siblings with Sickle Cell Disease
  3. Morbidity and Mortality in Transitioning sickle cell patients
  4. Fetal Hemoglobin Switching within Sickle Cell Trangenic Mice 

Biography

Dr. Andrew Campbell is a graduate of Case Western Reserve University School of Medicine, Cleveland. He completed a pediatric residency at Massachusetts General Hospital, Boston, and a fellowship in hematology/oncology at Children's Memorial Hospital /Northwestern University, Chicago. Dr. Campbell joined the faculty of the University of Michigan in 2002 and serves as an attending physician in the Pediatric Comprehensive Sickle Cell Center. His clinical interests focus on sickle cell disease and thalassemia. Dr. Campbell has a research interest in sickle cell disease including silent infarcts and neurocognitive functioning, the use of hydroxyurea, acute chest syndrome and pain management.